03:41 AM EDT, 06/09/2026 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said late Monday it priced an underwritten public offering expected to raise about $300 million in gross proceeds.

The company said it is selling 5.5 million shares at $27 per share and 5.6 million pre-funded warrants at $26.9999 each.

IDEAYA said it also granted underwriters a 30-day option to purchase up to 1.7 million additional shares, which could increase the size of the offering.

The offering is expected to close on Wednesday, it added.